Finch Therapeutics Group, Inc. (FNCH)

OTCMKTS: FNCH · Delayed Price · USD

1.370

+0.150 (12.30%)

Jul 2, 2024, 2:44 PM EDT - Market closed

Finch Therapeutics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0.11	0.86	18.53	7.72	10.15
Revenue Growth (YoY)	-87.57%	-95.35%	140.08%	-23.98%	-
Cost of Revenue	1.52	5.51	57.28	33.14	0.31
Gross Profit	-1.41	-4.65	-38.75	-25.43	9.84
Selling, General & Admin	26.91	38.09	21.24	14.01	7.44
Research & Development	5.68	57.89	57.28	33.14	23.54
Other Operating Expenses	4.05	0.95	1.83	0	0.04
Operating Expenses	32.59	95.98	78.52	47.16	30.98
Operating Income	-34	-115.59	-59.99	-39.44	-21.14
Interest Income	1.57	0.25	0.02	0.11	0.49
Interest Expense	0	35.44	0	0	0
Other Expense / Income	45.78	-36.13	-1.8	0.01	0.1
Pretax Income	-78.22	-114.65	-58.16	-39.34	-20.75
Income Tax	-3.46	-0.95	-2.3	-0.09	-0.35
Net Income	-74.75	-113.7	-55.86	-39.25	-20.41
Shares Outstanding (Basic)	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2
Shares Change	0.93%	0.38%	-1.57%	-	-
EPS (Basic)	-46.59	-71.52	-35.27	-24.39	-12.68
EPS (Diluted)	-46.59	-71.52	-35.27	-24.39	-12.68
Free Cash Flow	-31.51	-77.03	-83.12	-33.96	-18.33
Free Cash Flow Per Share	-19.63	-48.46	-52.48	-21.11	-11.39
Gross Margin	-1320.56%	-539.61%	-209.08%	-329.38%	96.91%
Operating Margin	-31777.57%	-13425.44%	-323.68%	-510.90%	-208.21%
Profit Margin	-69863.55%	-13205.46%	-301.42%	-508.46%	-200.97%
Free Cash Flow Margin	-29443.93%	-8946.92%	-448.50%	-439.98%	-180.47%
EBITDA	-32.48	-74.65	-59.99	-38.63	-20.52
EBITDA Margin	-30357.01%	-8669.80%	-323.68%	-500.49%	-202.09%
Depreciation & Amortization	1.52	5.51	2.3	0.79	0.48
EBIT	-34	-80.15	-62.29	-39.42	-21
EBIT Margin	-31777.57%	-9309.41%	-336.10%	-510.73%	-206.83%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.